Catalyst Wire Dossier Catalyst Wire Dossier

NEUROSTEM-AD

· Medipost Co Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NEUROSTEM-AD, covering 2012-04-23 to 2012-10-01. Get the full timeline:

Most recent: Clinical Trial Update: The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD

See pricing